From: Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours
 | PDO1 mean % | PDO2 mean % | PDO3 mean % | PDO4 mean % | PDO5 mean % |
---|---|---|---|---|---|
CD56 (NCAM) | 14.6 | 92.48 | 93.50 | 92.97 | 94.60 |
CD133 | 58.4 | 1.70 | 3.60 | 2.4 | 2.67 |
CD117 (c-kit) | 6.1 | 0.50 | 6.17 | 9.5 | 0.30 |
CD24 | 10.7 | 93.74 | 93.48 | 93.35 | 96.78 |
CD15-CD29-CD24+ (ND) | 0.04 | 70.81 | 72.16 | 77.63 | 91.47 |
CD14 | 0.3 | 1.2 | 0.6 | 0 | 0 |
CD20 | 1.2 | 0.3 | 1.35 | 0.75 | 0.95 |
CD45 | 2.4 | 1.65 | 2.85 | 1.70 | 0.80 |